Conmed (CNMD) FCF Payout Ratio Growth (1y) (2013 - 2025)
Conmed (CNMD) FCF Payout Ratio Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | 46.43% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -436.40% |
| 10 | Conmed | 1.34 Bn | 1.30 Bn | 183.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.46% |
| Sep 30, 2025 | -1.06% |
| Jun 30, 2025 | 70.46% |
| Mar 31, 2025 | -27.94% |
| Dec 31, 2024 | 31.75% |
| Sep 30, 2024 | -14.51% |
| Jun 30, 2024 | -43.81% |
| Mar 31, 2024 | 130.18% |
| Dec 31, 2023 | 133.81% |
| Sep 30, 2023 | -52.50% |
| Jun 30, 2023 | -39.05% |
| Mar 31, 2023 | 56.95% |
| Dec 31, 2022 | -284.92% |
| Sep 30, 2022 | -14.00% |
| Jun 30, 2022 | 143.63% |
| Mar 31, 2022 | -682.46% |
| Dec 31, 2021 | -43.30% |
| Sep 30, 2021 | 105.84% |
| Jun 30, 2021 | -94.18% |
| Mar 31, 2021 | -95.27% |